CIK 0001022079 · Large accelerated filer
QUEST DIAGNOSTICS INC
Sign in to watch- Ticker
- DGX
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 161387862
- Phone
- 9735202700
- Business address
- 500 PLAZA DRIVE, SECAUCUS, NJ, 07094
- Former names
- CORNING CLINICAL LABORATORIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $16,730,307
- in 5 filings, $16.7M under 10b5-1 plans
Net −$16,730,307. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- PREVOZNIK MICHAEL E −$5.5M SVP & General Counsel sold 38% of stake
- Doherty Catherine T. −$5.5M Executive Vice President sold 24% of stake
- Plewman Patrick −$3.0M SVP for Diagnostic Services sold 44% of stake
- Davis J. E. −$2.4M CEO and President sold 8% of stake
- PFEIFFER GARY M −$292K Director sold 4% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-02 | Davis J. E. CEO and President | Sale 10b5-1 | −584 | $168.70 | $99K | 130,738 |
| 2025-04-02 | Davis J. E. CEO and President | Sale 10b5-1 | −267 | $169.60 | $45K | 130,471 |
| 2025-04-02 | Davis J. E. CEO and President | Sale 10b5-1 | −1,493 | $167.88 | $251K | 128,978 |
| 2025-04-02 | Davis J. E. CEO and President | Sale 10b5-1 | −902 | $168.79 | $152K | 128,076 |
| 2025-04-02 | Davis J. E. CEO and President | Sale 10b5-1 | −453 | $169.63 | $77K | 127,623 |
| 2025-04-02 | KUPPUSAMY KARTHIK SVP, Clinical Solutions | Sale 10b5-1 | −2,555 | $170.00 | $434K | 10,575 |
| 2025-04-01 | Lassiter Wright III Director | Grant or award · Phantom Stock Units | +169 | 359.91 | ||
| 2025-04-01 | RING TIMOTHY M Director | Grant or award · Phantom Stock Units | +251 | 16,409.56 | ||
| 2025-03-26 | Plewman Patrick SVP for Diagnostic Services | Shares withheld for taxes | −162 | $166.71 | $27K | 20,988 |
| 2025-03-26 | DELANEY MARK E SVP & Chief Commercial Officer | Shares withheld for taxes | −256 | $166.71 | $43K | 9,221 |
| 2025-03-17 | PREVOZNIK MICHAEL E SVP & General Counsel | Sale 10b5-1 | −4,643 | $170.00 | $789K | 38,117 |
| 2025-03-05 | Doherty Catherine T. EVP, Regional Businesses | Sale 10b5-1 | −5,370 | $174.13 | $935K | 68,068 |
| 2025-03-04 | DEPPE MICHAEL J SVP, Corp. Controller & CAO | Grant or award | +1,711 | $173.74 | $297K | 35,232 |
| 2025-03-04 | DEPPE MICHAEL J SVP, Corp. Controller & CAO | Shares withheld for taxes | −867 | $173.74 | $151K | 34,365 |
| 2025-03-04 | Doherty Catherine T. EVP, Regional Businesses | Sale 10b5-1 | −716 | $175.79 | $126K | 68,068 |
| 2025-03-04 | Doherty Catherine T. EVP, Regional Businesses | Grant or award 10b5-1 | +10,380 | $173.74 | $1.8M | 78,448 |
| 2025-03-04 | Doherty Catherine T. EVP, Regional Businesses | Shares withheld for taxes 10b5-1 | −5,010 | $173.74 | $870K | 73,438 |
| 2025-03-04 | Davis J. E. CEO and President | Grant or award | +61,917 | $173.74 | $10.8M | 198,470 |
| 2025-03-04 | Davis J. E. CEO and President | Shares withheld for taxes | −31,656 | $173.74 | $5.5M | 166,814 |
| 2025-03-04 | KUPPUSAMY KARTHIK SVP, Clinical Solutions | Grant or award | +4,434 | $173.74 | $770K | 14,998 |
Page 13 of 21 · 409 trades